ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $445,000 | +20.9% | 4,791 | -22.6% | 0.01% | +25.0% |
| Q3 2021 | $368,000 | -93.4% | 6,191 | -92.4% | 0.01% | -92.0% |
| Q2 2021 | $5,537,000 | -22.3% | 81,205 | -20.9% | 0.10% | -24.2% |
| Q1 2021 | $7,125,000 | +202.4% | 102,709 | +234.8% | 0.13% | +135.7% |
| Q4 2020 | $2,356,000 | -3.0% | 30,679 | -5.6% | 0.06% | -39.1% |
| Q3 2020 | $2,428,000 | +887.0% | 32,484 | +729.7% | 0.09% | +607.7% |
| Q2 2020 | $246,000 | +68.5% | 3,915 | +12.5% | 0.01% | +30.0% |
| Q1 2020 | $146,000 | -11.5% | 3,480 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $165,000 | +38.7% | 3,480 | +33.6% | 0.01% | +10.0% |
| Q3 2019 | $119,000 | – | 2,604 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |